G. Lowman

TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer

C. Morrison, J. Conroy, L. Fong, 2019, bioRxiv.

TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer

C. Morrison, J. Conroy, L. Fong, 2019, bioRxiv.

Haplotype Analysis of the T-Cell Receptor Beta (TCRB) Locus by Long-amplicon TCRB Repertoire Sequencing

C. Morrison, F. Meric-Bernstam, Linghua Wang, 2019, Journal of Immunotherapy and Precision Oncology.

Haplotype Analysis of the TRB Locus by TCRB Repertoire Sequencing

C. Morrison, F. Meric-Bernstam, Linghua Wang, 2018, bioRxiv.

TCR beta chain convergence defines the tumor infiltrating T cell repertoire of melanoma and non-small cell lung carcinoma.

G. Lowman, E. Linch, L. Miller, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma

Amy Rose, J. Kirkwood, H. Tawbi, 2021, Journal for ImmunoTherapy of Cancer.

The Epithelial–Stromal Microenvironment in Early Colonic Neoplasia

C. Giardina, Boyang Li, D. Rosenberg, 2021, Molecular Cancer Research.

T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy

F. Meric-Bernstam, S. Patel, Linghua Wang, 2023, Journal for ImmunoTherapy of Cancer.

Evaluating the link between T cell receptor beta variable gene polymorphism and immune mediated adverse events during checkpoint blockade immunotherapy.

T. Looney, D. Topacio-Hall, G. Lowman, 2018 .